Recent studies suggest that the IFN-JAK1/2-STAT1 pathway plays a central role in T cell-mediated killing of tumor cells; and perturbation of this pathway leads to resistance of immune check point blockade in melanoma15,16. The gene discussed is STAT1; the disease is neoplasm.